mRNA vaccines for infections and beyond
Matthew Snape is a paediatrician who joined Moderna in 2022 to lead their Paediatric and Maternal Clinical Development team.
Prior to this he worked as the NIHR Oxford BRC Consultant in Vaccinology and Pediatrics at the Oxford Vaccine Group (University of Oxford) and the Oxford Children’s Hospital.
Research interests while at the Oxford Vaccine Group included leading phase 1 to 4 studies on vaccines against pathogens such as RSV, Ebola virus, Influenza, Pneumococcus and Meningococcus. From 2017 to 2022 he led the NIHR funded National Immunisation Schedule Evaluation Consortium (NISEC), tasked with conducting research studies of relevance to UK immunisation policy. In this role he lead the ‘COM-COV’ trials studying heterologous COVID-19 vaccine schedules
Matthew Snape is originally from Melbourne, Australia, where he trained in Paediatrics at the Royal Children’s Hospital.
Date:
11 November 2024, 13:00 (Monday, 5th week, Michaelmas 2024)
Venue:
Big Data Institute, Old Road Campus OX3 7LF
Venue Details:
Seminar Rooms
Speaker:
Prof Matthew Snape (Moderna)
Organising department:
Nuffield Department of Population Health
Organiser:
Professor Angela Brueggemann (Oxford Population Health)
Organiser contact email address:
alison.lewis@ndph.ox.ac.uk
Host:
Professor Angela Brueggemann (Oxford Population Health)
Part of:
IDEU Infectious Disease Seminar Series
Booking required?:
Not required
Audience:
Members of the University only
Editors:
Alison Lewis,
Angela Brueggemann
